0001654954-22-000127.txt : 20220104
0001654954-22-000127.hdr.sgml : 20220104
20220104142717
ACCESSION NUMBER: 0001654954-22-000127
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20211231
FILED AS OF DATE: 20220104
DATE AS OF CHANGE: 20220104
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Tsuchimoto Kim R
CENTRAL INDEX KEY: 0001333516
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39070
FILM NUMBER: 22505279
MAIL ADDRESS:
STREET 1: C/O MONOPAR THERAPEUTICS INC.
STREET 2: 1000 SKOKIE BLVD., SUITE 350
CITY: WILMETTE
STATE: IL
ZIP: 60091
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Monopar Therapeutics
CENTRAL INDEX KEY: 0001645469
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 320463781
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1000 SKOKIE BLVD SUITE 350
CITY: WILMETTE
STATE: IL
ZIP: 60091
BUSINESS PHONE: 8473880349
MAIL ADDRESS:
STREET 1: 1000 SKOKIE BLVD SUITE 350
CITY: WILMETTE
STATE: IL
ZIP: 60091
4
1
section16.xml
PRIMARY DOCUMENT
X0306
4
2021-12-31
false
0001645469
Monopar Therapeutics
MNPR
0001333516
Tsuchimoto Kim R
1000 SKOKIE BLVD SUITE 350
WILMETTE
IL
60091
false
true
false
false
Chief Financial Officer
Common Stock
2021-12-31
4
M
false
1221
A
4690
D
Common Stock
2021-12-31
4
F
false
501
3.21
D
4189
D
Restricted Stock Units
2021-12-31
4
M
false
1221
0
D
Common Stock
1221
14652
D
Represents shares acquired on vesting and settlement of restricted stock units.
On January 26, 2021, the reporting person was granted 19,536 restricted stock units, vesting 6/48ths (2,442 shares) on June 30, 2021, and 3/48ths (1,221 shares) every 3 months thereafter until the RSU is fully vested on December 31, 2024. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement.
/s/ Kim R. Tsuchimoto
2022-01-04